Costs and benefits of rapid screening of methicillin-resistant Staphylococcus aureus carriage in intensive care units: a prospective multicenter study
Authors:
- Marjan WassenbergMWMarjan Wassenberg
- Jan KluytmansJKJan Kluytmans
- Stephanie ErdkampSEStephanie Erdkamp
- Ron BosboomRBRon Bosboom
- Anton BuitingABAnton Buiting
- Erika van ElzakkerEEErika van Elzakker
- Willem MelchersWMWillem Melchers
- Steven ThijsenSTSteven Thijsen
- Annet TroelstraATAnnet Troelstra
- Christina Vandenbroucke-GraulsCVChristina Vandenbroucke-Grauls
- Caroline VisserCVCaroline Visser
- Andreas VossAVAndreas Voss
Open Access
- 7 February 2012
- journal article
- research article
- Published by Springer Nature in Critical Care
- Vol. 16 (1) , R22
Abstract
Introduction: Pre-emptive isolation of suspected methicillin-resistant Staphylococcus aureus (MRSA) carriers is a cornerstone of successful MRSA control policies. Implementation of such strategies is hampered when using conventional cultures with diagnostic delays of three to five days, as many non-carriers remain unnecessarily isolated. Rapid diagnostic testing (RDT) reduces the amount of unnecessary isolation days, but costs and benefits have not been accurately determined in intensive care units (ICUs). Methods: Embedded in a multi-center hospital-wide study in 12 Dutch hospitals we quantified cost per isolation day avoided using RDT for MRSA, added to conventional cultures, in ICUs. BD GeneOhm™ MRSA PCR (IDI) and Xpert MRSA (GeneXpert) were subsequently used during 17 and 14 months, and their test characteristics were calculated with conventional culture results as reference. We calculated the number of pre-emptive isolation days avoided and incremental costs of adding RDT. Results: A total of 163 patients at risk for MRSA carriage were screened and MRSA prevalence was 3.1% (n = 5). Duration of isolation was 27.6 and 21.4 hours with IDI and GeneXpert, respectively, and would have been 96.0 hours when based on conventional cultures. The negative predictive value was 100% for both tests. Numbers of isolation days were reduced by 44.3% with PCR-based screening at the additional costs of €327.84 (IDI) and €252.14 (GeneXpert) per patient screened. Costs per isolation day avoided were €136.04 (IDI) and €121.76 (GeneXpert). Conclusions: In a low endemic setting for MRSA, RDT safely reduced the number of unnecessary isolation days on ICUs by 44%, at the costs of €121.76 to €136.04 per isolation day avoided.Keywords
This publication has 21 references indexed in Scilit:
- Diagnostic accuracy of culture-based and PCR-based detection tests for methicillin-resistant Staphylococcus aureus: a meta-analysisClinical Microbiology and Infection, 2011
- Costs and benefits of the MRSA Search and Destroy policy in a Dutch hospitalEuropean Journal of Clinical Microbiology & Infectious Diseases, 2009
- Multicenter Evaluation of the Cepheid Xpert Methicillin-Resistant Staphylococcus aureus (MRSA) Test as a Rapid Screening Method for Detection of MRSA in NaresJournal of Clinical Microbiology, 2009
- Effect of Screening for Methicillin-Resistant Staphylococcus aureus Carriage by Polymerase Chain Reaction on the Duration of Unnecessary Preemptive Contact IsolationInfection Control & Hospital Epidemiology, 2008
- Evaluation of the Xpert Methicillin-Resistant Staphylococcus aureus (MRSA) Assay Using the GeneXpert Real-Time PCR Platform for Rapid Detection of MRSA from Screening SpecimensJournal of Clinical Microbiology, 2008
- Impact of routine surgical ward and intensive care unit admission surveillance cultures on hospital-wide nosocomial methicillin-resistant Staphylococcus aureus infections in a university hospital: an interrupted time-series analysisJournal of Antimicrobial Chemotherapy, 2008
- Impact of Routine Intensive Care Unit Surveillance Cultures and Resultant Barrier Precautions on Hospital‐Wide Methicillin‐ResistantStaphylococcus aureusBacteremiaClinical Infectious Diseases, 2006
- National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004American Journal of Infection Control, 2004
- Comparison of Mortality Associated with Methicillin‐Resistant and Methicillin‐SusceptibleStaphylococcus aureusBacteremia: A Meta‐analysisClinical Infectious Diseases, 2003
- Costs Associated with a Strict Policy to Eradicate Methicillin-Resistant Staphylococcus aureus in a Dutch University Medical Center: A 10-Year SurveyEuropean Journal of Clinical Microbiology & Infectious Diseases, 2002